LENZ Therapeutics’ Post

🌎 Our world-class Life Sciences M&A Team has been on a tear in the last couple months having completed a trio of BIG deals (links in the comments)… ✅ Represented Deciphera Pharmaceuticals in its $2.4 billion acquisition by ONO Pharmaceutical ✅ Represented Fusion Pharmaceuticals in its $2.4 billion acquisition by AstraZeneca ✅ Represented Mariana Oncology in its $1 billion acquisition by Novartis 🔥M&A is really heating up… and these transactions are complex (and in some cases, groundbreaking) and require highly strategic and deeply knowledgeable counsel to successfully guide them to completion. 🎖️Hats off to the incredible #teams at Goodwin who worked on these deals… and to the Co-Chairs of our Global Life Sciences M&A Practice, Graham Defries, Danielle Lauzon and Robert Masella for their strategic leadership in keeping us at the top of the mountain here! And congratulations to our amazing clients - wouldn’t be here without you! #premiere #lifesciences #legal #strategists #MandA #goodwinlaw

Thoughts on this? >> Neurocrine CEO Kevin Gorman to retire after 32-year run; Bluebird picks up fifth CFO in three years >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #pharma #productmarketing #healthcare

Thoughts on this? >> Neurocrine CEO Kevin Gorman to retire after 32-year run; Bluebird picks up fifth CFO in three years >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #pharma #productmarketing #biotech

A great pairing if you ask me! Two of Cooley's most prolific attorneys talk to Law360 about the #Cooley difference. Since facilitating the first biotech IPO in history, our attorneys have remained at the forefront of the innovation ecosystem, expertly guiding clients from R&D to Commercialization and beyond, and everything in between. Check it out... cc: Marc Recht & Chad Shear

We've successfully implemented a dedicated Business Unit for some of our biotech partners, reinforcing – with our partnering model – our commitment to tailored, efficient clinical trial management. #BiotechPartnership #BusinessInnovation

In an article spotlighting Cooley’s 2023 Life Sciences Group of the Year recognition, Law360 spoke with partners Marc Recht and Chad Shear, as they discussed how the firm's longstanding biotech industry leadership, collaborative workplace culture and breadth of practice play key roles in Cooley's accomplishments across the life sciences ecosystem. Subscribers can read more with the link below. Cooley's global life sciences practice spans corporate, litigation, regulatory and intellectual property capabilities, with almost 280 partners, associates, paralegals and other legal professionals attached to life sciences work of some kind across all 19 offices. Learn more here: https://bit.ly/49Kvv8f #lifesciences #leadership #biotech #TeamCooley

During my undergraduate studies, I aimed to work in the biotech 💉 industry. Since pivoting into the legal ⚖ practice, I'm all-the-more happy to have landed at Fenwick & West, which has a dual-focus on both the general tech sector and the life sciences sector. This duality has shaped my own patent prosecution practice with a core focus on the overlap of machine-learning techniques as applied to biotech research & development. 🏆 🎉 #LifeSciences #Healthtech #PGOTY

In this episode of #CannabisUnlocked, Katie Neer Esq. (Of Counsel at Dickinson & Avella, PLLC) sits down with Jordan Youkilis (Founding Partner at KEY Investment Partners) to discuss the New York cannabis market and the opportunity it holds for those willing to navigate its complex regulatory structure. Please enjoy! #cannabisinvestment #nyccannabis #newyorkcannabis #cannabislegalization

Fresh Tracks' board supports company liquidation, shareholder meeting in Q4 >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #biotech #pharma #pharmaceutical #productmarketing

Landmark CRISPR approval; Why don't investors like Verve’s base editing data?; Janet Woodcock to retire; Late Friday IPO filing; and more >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #productmarketing #pharmaceutical #biotech #pharma